{"id":1534,"date":"2021-10-26T12:01:11","date_gmt":"2021-10-26T12:01:11","guid":{"rendered":""},"modified":"2021-11-30T16:17:39","modified_gmt":"2021-11-30T16:17:39","slug":"page-2215","status":"publish","type":"post","link":"https:\/\/copolad.fiiapp.quentalstaging.com\/es\/page-2215\/","title":{"rendered":"EMCDDA update on the implications of COVID-19 for people who use drugs (PWUD) and drug service providers"},"content":{"rendered":"<div id=\"articleHeader\"><strong style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen-Sans, Ubuntu, Cantarell, 'Helvetica Neue', sans-serif;\">EMCDDA<\/strong><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen-Sans, Ubuntu, Cantarell, 'Helvetica Neue', sans-serif;\">. European Monitoring Centre for Drugs and Drug Addiction<\/span><\/div>\n<section>\n<div>\n<p>The purpose of this briefing is to highlight emerging risks linked to the COVID-19 pandemic for people who use drugs and those providing services for them from a European perspective, and where necessary to encourage planning, review and adaption of frontline and specialist drug interventions.<\/p>\n<\/div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<p>La Comisi\u00f3n Europea est\u00e1 preparando una tercera fase de este programa, por lo que COPOLAD volver\u00e1 a principios de 2021.<\/p>\n<p><a title=\"Acceder en ingl\u00e9s\" href=\"https:\/\/copolad.eu\/wp-content\/uploads\/attachments\/emcdda-covid-update-1-25.03.2020v2.pdf\" target=\"_blank\" rel=\"noopener\">Acceder en ingl\u00e9s<\/a><\/p>\n<div><a href=\"http:\/\/copolad.eu\/es\/newsletter\/copolad-atlas-final?view_lang=es\" target=\"_blank\" rel=\"noopener\">Carta final COPOLAD II<br \/>\n<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>EMCDDA. European Monitoring Centre for Drugs and Drug Addiction The purpose of this briefing is to highlight emerging risks linked to the COVID-19 pandemic for people who use drugs and those providing services for them from a European perspective, and where necessary to encourage planning, review and adaption of frontline and specialist drug interventions. La [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":1535,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/copolad.fiiapp.quentalstaging.com\/es\/wp-json\/wp\/v2\/posts\/1534"}],"collection":[{"href":"https:\/\/copolad.fiiapp.quentalstaging.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/copolad.fiiapp.quentalstaging.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/copolad.fiiapp.quentalstaging.com\/es\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/copolad.fiiapp.quentalstaging.com\/es\/wp-json\/wp\/v2\/comments?post=1534"}],"version-history":[{"count":0,"href":"https:\/\/copolad.fiiapp.quentalstaging.com\/es\/wp-json\/wp\/v2\/posts\/1534\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/copolad.fiiapp.quentalstaging.com\/es\/wp-json\/wp\/v2\/media\/1535"}],"wp:attachment":[{"href":"https:\/\/copolad.fiiapp.quentalstaging.com\/es\/wp-json\/wp\/v2\/media?parent=1534"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/copolad.fiiapp.quentalstaging.com\/es\/wp-json\/wp\/v2\/categories?post=1534"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/copolad.fiiapp.quentalstaging.com\/es\/wp-json\/wp\/v2\/tags?post=1534"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}